Innova Captab Limited

Healthcare · Pharmaceuticals & Biotechnology

NSE: INNOVACAP BSE: 544067
₹1159.80
▼ -111.40 (-8.76%)
Sept. 30, 2026 · NSE · nse_bhavcopy
Quality
70/100
Moderate
Valuation
—/100
Expensive
Momentum
50/100
Neutral

QVM read Mixed signals Quality Moderate, Valuation Expensive, Momentum Neutral

Tradinity's own scoring, not a copy of any third party's -- see the Key Metrics section for the real ratios behind each number.

Key Metrics

Market Capitalization
₹6,637 Cr
PE (TTM)
69.5
Industry median 36.1 (152 companies)
Price to Book
6.9
PEG (TTM)
7.6
Institutions holding %
20.26%
FII + DII, latest filed period
Piotroski Score
Data unavailable.
Relative return vs Nifty50, qtr %
27.5
Relative return vs Sector, qtr %
19.2
Free Cash Flow
₹-13 Cr
as of Sept. 30, 2025
Industry median ₹-0 Cr (198 companies)
EPS Growth (YoY)
57.75%
as of June 30, 2026
Industry median 26.14% (180 companies)
Net Profit Growth (TTM)
9.18%
as of June 30, 2026
Industry median 6.21% (175 companies)
Operating Revenue Growth (TTM)
38.71%
as of June 30, 2026
Industry median 9.08% (175 companies)
Profit Growth (YoY)
57.97%
as of June 30, 2026
Industry median 22.20% (176 companies)
Revenue Growth (YoY)
39.55%
as of June 30, 2026
Industry median 14.05% (173 companies)
Current Ratio
1.87
as of March 31, 2026
Industry median 1.84 (197 companies)
Debt to Equity
0.35
as of March 31, 2025
Industry median 0.14 (186 companies)
Interest Coverage
8.64
as of June 30, 2026
Industry median 10.58 (182 companies)
Net Margin
8.01%
as of June 30, 2026
Industry median 9.35% (179 companies)
Operating Margin (EBIT)
11.75%
as of June 30, 2026
Industry median 14.22% (181 companies)
Operating Margin (TTM)
10.21%
as of June 30, 2026
Industry median 12.41% (182 companies)
Return on Assets
5.41%
as of March 31, 2026
Industry median 5.54% (180 companies)
Return on Capital Employed
11.23%
as of March 31, 2026
Industry median 12.43% (181 companies)
Return on Equity
13.37%
as of March 31, 2025
Industry median 9.66% (179 companies)

Investment checklist

Tradinity's own yes/no questions with the rule stated beside each. “Items without enough data are left out, never counted as a No, and the totals count only answered questions. A summary of numbers on this page, not advice.

Financials

2 of 5 met
  • No Net profit is higher than a year earlier in each of the last 4 quarters
  • Yes Revenue is higher than a year earlier in each of the last 4 quarters
  • No Quality score is Strong (70 or more)
  • Yes Debt to equity is below 0.5 (0.35)
  • No Return on equity is 15% or more (13.4%)

Ownership

4 of 4 met
  • Yes FII/FPI or DII holding rose in the latest quarter
  • Yes Promoter holding rose or was unchanged in the latest quarter
  • Yes Promoter pledge is 5% of their holding or less and not rising (0.0% pledged)
  • Yes Insiders have not sold in the past 3 months (no open-market sale filed in the last 3 months)

Peer comparison

3 of 3 met
  • Yes 1-year return beats the industry median
  • Yes Revenue growth beats the industry median
  • Yes Profit growth beats the industry median

Value and momentum

1 of 6 met
  • No Price sits in the Buy zone of its own historical PE range (Overvalued (above its own historical PE range))
  • No Valuation score is Undervalued (70 or more)
  • No Momentum score is Bullish (70 or more)
  • No Price is above the 5, 10 and 20 day averages
  • Yes Price is above the 50, 100 and 200 day averages
  • No Latest candle has a bullish shape (hammer, dragonfly doji, white marubozu)

Price

Download CSV

PE/EPS use each quarter's real filed EPS only from 45 days after quarter-end (no look-ahead) against the raw close of the day. Price-to-book isn't a mode here: the feed has no dated share count, so there's no real history to chart.

RSI (14) (same adjusted close series as the price chart above)

MACD (12, 26, 9) (same adjusted close series as the price chart above)

Relative Returns (vs NIFTY 50)

Prices adjusted for splits and bonuses. * = a corporate action affecting this date could not be parsed and is not reflected.

Price range

Day return
-8.8%
Low 1146.5000 · High 1270.0000
1W return
-10.6%
Low 1146.5000 · High 1322.9000
1M return
7.6%
Low 1052.1000 · High 1353.5000
52W return
33.0%
Low 622.0000 · High 1353.5000
Lifetime High ₹1297.6000 (Sept. 23, 2026)
Lifetime Low ₹449.5500 (March 28, 2024)

Full price history and technicals →

EMA & SMA

Bullish3
Bearish3
5D
1230.6
10D
1225.1
20D
1190.3
50D
1106.9
100D
1014.9
200D
854.7

Delivery and volume

Day avg. delivery
39.1%
Week avg. delivery
77.5%
Month avg. delivery
58.7%

Week = 5 sessions, Month = 22 sessions ending the latest trading day — the same combined NSE+BSE delivery data as the table below, just summed.

Resistance and support

1192.10
Pivot
First resistance1237.70
Second resistance1315.60
Third resistance1361.20
First support1114.20
Second support1068.60
Third support990.70
Day RSI48.9
Day MFI56.9
Day MACD48.32
Day MACD signal50.81

Beta

1M1.10
3M0.09
1Y0.41
3Y0.79

Price change analysis

↑ 7.6%
Over 1 Month
LowHigh
1052.101353.50
↑ 19.2%
Over 3 Months
LowHigh
925.201353.50
↑ 64.8%
Over 6 Months
LowHigh
670.001353.50
↑ 33.0%
Over 1 Year
LowHigh
622.001353.50
Legend Positive indicator Neutral indicator Negative indicator

Buy/Sell Zone

View Buy/Sell Zone →
Current PE 69.5 (own history: 37.3–69.3)
Overvalued (above its own historical PE range)
Revenue (June 30, 2026)
₹400 Cr
Net profit (June 30, 2026)
₹32 Cr
Basic EPS (June 30, 2026)
₹5.6000

Ranks #54 of 184 in Pharmaceuticals & Biotechnology by market cap -- full peer table on the Financials page.

Shareholding pattern / Ownership

Shareholding summary

Jun 2026
  • Promoter50.90%
  • Mutual funds9.18%
  • FII/FPI0.34%
  • Other DII10.74%
  • Public28.84%

Largest holders

NameCategoryShares %Shares
MANOJ LOHARIWALAPromoter29.0700%16636446
VINAY KUMAR LOHARIWALAPromoter21.8100%12482875
GIAN PARKASH AGGARWALPublic10.8000%6182464
ARCHIT AGGARWALPublic8.7400%5000000
KOTAK MAHINDRA TRUSTEE CO LTD A/C KOTAK MULTICAP FPublic3.6400%2085803

As of June 30, 2026. Only holders the filing discloses individually.

Historical promoter holding

Promoters holdings were unchanged at 50.90% in Jun 2026 qtr

Historical fii holding

FII/FPI holdings increased from 0.23% to 0.34% in Jun 2026 qtr

Historical mutual fund holding

Mutual funds holdings decreased from 10.50% to 9.18% in Jun 2026 qtr

5 mutual fund schemes also hold this stock.

All shareholding details →

Insider trading, SAST & pledges

All 5 insider trades, 4 SAST, 0 pledge events →

Latest insider trades

FiledPersonCategoryTypeQuantityValue
25 Mar 2026 Archit Aggarwal Director Pledge 0 ₹302.31 Cr
18 Nov 2025 Gian Parkash Aggarwal Immediate relative Pledge 0 ₹21.07 Cr
18 Nov 2025 Gian Parkash Aggarwal Immediate relative Pledge 0 ₹18.81 Cr
30 Sep 2025 Gian Parkash Aggarwal Immediate relative Pledge 0 ₹81.32 Cr
30 Sep 2025 Gian Parkash Aggarwal Immediate relative Pledge 0 ₹106.86 Cr

All insider and SAST disclosures →

DateClientDealActionQuantityPriceExchange
30 Sep 2026 SBI MUTUAL FUND Bulk Buy 833,250 1080.0000 BSE
30 Sep 2026 GIAN PARKASH AGGARWAL Bulk Sell 1,550,000 1080.0400 BSE
1 Jan 2024 GRAVITON RESEARCH CAPITAL LLP Bulk Buy 477,528 525.6800 NSE
1 Jan 2024 GRAVITON RESEARCH CAPITAL LLP Bulk Sell 477,528 525.7000 NSE
29 Dec 2023 MANSI SHARE & STOCK ADVISORS PRIVATE LIMITED Bulk Buy 200,438 539.0000 BSE
29 Dec 2023 MANSI SHARE & STOCK ADVISORS PRIVATE LIMITED Bulk Sell 355,735 542.6400 BSE

All bulk and block deals →

Last 12 months ₹2.00 per share
Dividend yield 0.17%
Ex-dateSubjectPer share (₹)Record date
30 Jan 2026 Interim Dividend - Rs 2 Per Share 2.0000 30 Jan 2026

Quarterly results, AGMs, buybacks and other board-approved business.

DatePurposeResults
21 Aug 2026 Financial Results Yes
11 Aug 2026 Financial Results Yes
7 May 2026 Financial Results/Other business matters Yes
23 Jan 2026 Financial Results/Dividend/Other business matters Yes
7 Nov 2025 Financial Results/Other business matters Yes

Corporate Announcements

All 227 announcements, with search →

Exchange disclosures (NSE and BSE), most recent first.

DateCategoryAnnouncement
2 Oct 2026 Shareholders meeting Innova Captab Limited has submitted the Exchange a copy Srutinizers report of Annual General Meeting held on September 30, 2026. Further, the company has informed the Exchange regarding voting results.
30 Sep 2026 AGM/EGM Innova Captab Ltd - 544067 - Shareholder Meeting / Postal Ballot-Outcome of AGM
30 Sep 2026 Shareholders meeting Innova Captab Limited has informed the Exchange about Shareholders meeting
29 Sep 2026 Credit Rating- Revision Innova Captab Limited has informed the Exchange about Credit Rating- Revision
29 Sep 2026 Company Update Innova Captab Ltd - 544067 - Announcement under Regulation 30 (LODR)-Credit Rating
28 Sep 2026 Insider Trading / SAST Innova Captab Ltd - 544067 - Closure of Trading Window
28 Sep 2026 Trading Window Innova Captab Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015
15 Sep 2026 Company Update Innova Captab Ltd - 544067 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
15 Sep 2026 Analysts/Institutional Investor Meet/Con. Call Updates Innova Captab Limited has informed the Exchange about Schedule of meet
5 Sep 2026 Company Update Innova Captab Ltd - 544067 - Announcement under Regulation 30 (LODR)-Newspaper Publication

All announcements →

SWOT

Tradinity's own rule-based read of the real ratios elsewhere on this page -- not a copy of any third party's, and never a forward-looking prediction.

Strengths

  • Healthy liquidity (Current Ratio 1.87)
  • Strong revenue growth YoY (39.5%)

Weaknesses

Data unavailable.

Opportunities

Data unavailable.

Threats

  • PE above 35 (69.5) -- priced for continued strong execution

Data unavailable (no single-stock futures or options activity on record for this company).

Frequently asked questions about Innova Captab Limited

Where is the share price?

The price at the top of this page is the last traded price from exchange data; during market hours it refreshes on its own. The Chart & Technicals section has the full price history.

Where are the financial results?

The Financials page has quarterly and annual results, ratios, cash flow and the balance sheet, on a standalone or consolidated basis.

Who owns the company?

The Ownership section shows the latest shareholding pattern from exchange filings, with promoter, FII, DII and public holdings by quarter.

Does Tradinity give buy or sell advice?

No. The scores and checklist on this page are rule-based summaries of published figures, not recommendations. Tradinity is not a registered investment adviser.